Streetbeat News

Assets

ELTX

Elicio Therapeutics has reported preliminary relapse-free survival data from its ongoing Phase 1 study of its lead asset, ELI-002.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 9:40 pm

VSEC

VSE Corporation has mutually agreed to terminate the sale of its Federal and Defense segment to Bernhard Capital Partners. The deal was initially announced on May 1, 2023, and no termination fee will be required. The VSE Federal and Defense segment will remain in discontinued operations as the assets are held for sale.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 9:33 pm

TRI

Thomson Reuters (NYSE:TRI) has outperformed the market over the past 10 years by 2.21% on an annualized basis, producing an average annual return of 11.87%. If an investor had bought $1000 of TRI stock 10 years ago, it would be worth $3,085.99 today.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 9:30 pm

AME

AMETEK (NYSE:AME) has outperformed the market over the past 15 years, producing an average annual return of 15.62%. If an investor had bought $1000 of AME stock 15 years ago, it would be worth $8,239.48 today.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 9:30 pm

PRCH

Porch Group has invested $57M in cash in HOA, its insurance carrier. The investment is in exchange for a $49M surplus note from HOA and the acquisition of HOA's rights to potential claims related to the fraud connected to Vesttoo Ltd. and others.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 9:09 pm

SJM

J.M. Smucker has agreed to sell its Sahale Snacks brand to Second Nature Brands for $34M in an all-cash transaction. The deal includes all trademarks and a leased manufacturing facility in Seattle, along with about 100 employees. The company expects the impact of the sale to be immaterial to its adjusted earnings per share on a full-year basis.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 9:03 pm

LIN

Linde (NYSE:LIN) has outperformed the market over the past 5 years by 9.21% on an annualized basis, producing an average annual return of 17.09%. If an investor had bought $1000 of LIN stock 5 years ago, it would be worth $2,202.94 today.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 9:00 pm

INFY

Infosys (NYSE:INFY) has outperformed the market over the past 10 years, producing an average annual return of 11.1%. If an investor had bought $1000 of INFY stock 10 years ago, it would be worth $2,900.02 today.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 9:00 pm

FTLF

FitLife Brands is set to acquire substantially all of the assets of MusclePharm for $18.5M, subject to customary adjustments. The all-cash transaction is expected to be highly accretive to existing shareholders once all transaction-related costs have been expensed. The transaction is expected to close by October 16, 2023.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 8:50 pm

VALE

A large investor has taken a bullish stance on Vale (NYSE:VALE), with 72% of big-money traders also bullish. The investor's position was noticed through publicly available options history. The options scanner spotted 11 uncommon options trades for Vale, with 4 puts and 7 calls. The whales have been targeting a price range from $3.0 to $20.0 for Vale over the last 3 months. JP Morgan has upgraded its action to Overweight with a price target of $16 and maintained their Overweight rating on Vale with a price target of $18.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 8:46 pm